Multiple Sclerosis

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Get help with your application

Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.

parasiteatwork

Senior Member
10+ Year Member
5+ Year Member
15+ Year Member
Advertisement - Members don't see this ad
Hello
I am very new to the field of neurology and am supposed to write a paper on- "The benefits of Novatrom treatment in secondary progressive Multiple Sclerosis". I was wondering if anyone could give me some internet sites from where i could get some information.
Thanks
 
parasiteatwork said:
Hello
I am very new to the field of neurology and am supposed to write a paper on- "The benefits of Novatrom treatment in secondary progressive Multiple Sclerosis". I was wondering if anyone could give me some internet sites from where i could get some information.
Thanks

To do some honest reseach? http://www.pubmed.gov

To copy information from? http://loser.before-reality.net/
 
parasiteatwork said:
Hello
I am very new to the field of neurology and am supposed to write a paper on- "The benefits of Novatrom treatment in secondary progressive Multiple Sclerosis". I was wondering if anyone could give me some internet sites from where i could get some information.
Thanks

Perhaps you mean "Novantrone" (also known as mitoxantrone)?
Try plugging that into a google search and you should get plenty.

And hey, how about that natalizumab? 👎 👎 👎
Didn't even survive as long as the Cox 2's before it was yanked today! And to think I was just considering throwing my 1st couple of patients on it . . . .
 
Advertisement - Members don't see this ad
neurologist said:
And hey, how about that natalizumab? 👎 👎 👎
Didn't even survive as long as the Cox 2's before it was yanked today! And to think I was just considering throwing my 1st couple of patients on it . . . .

Yeah, that is a bummer. Galetta at UPenn gave us a noon lecture on the preliminary results during interview day in November. It seemed extremely promising...
 
GopherBrain said:
Yeah, that is a bummer. Galetta at UPenn gave us a noon lecture on the preliminary results during interview day in November. It seemed extremely promising...

So did Felbamate, way back when . . .
And Trovan . . .
And FenPhen . . .
And Clozaril . . .
And troglitazone . . .
And cisapride . . .

The list goes on . . . .

As long as we delude ourselves into thinking that medications can and/or should be 100% safe for all patients under all circumstances, we're going to miss out on a lot of "promising" possibilities.

Tylenol has killed more people than all the above combined.